Learning Hub Central
Targeted Therapy
Hippo-Yap Pathway
Targeted Therapy
Non-CME Credit Course
Targeted Therapy and Resistance, New Agents are Coming
Targeted Therapy
Non-CME Credit Course
Artificial Intelligence in Cancer Therapeutics: Fact or Fiction?
Targeted Therapy
Non-CME Credit Course
Treatment of Patients Progressing after BTKi and BCL2i
Targeted Therapy
Non-CME Credit Course
Targeted Therapy in NSCLC
Targeted Therapy
Non-CME Credit Course
Updates in NSCLC Targeted Therapy
Targeted Therapy
Non-CME Credit Course
The Era of Antibody-Drug Conjugates (ADCs) and Bi-Specifics
Targeted Therapy
Non-CME Credit Course
Moving the Bar Beyond PACIFIC. What is the Best Consolidation Therapy for People with Actionable and Non-Actionable Genes?
Targeted Therapy
Non-CME Credit Course
Which Patients Need Adjuvant Therapy?
Targeted Therapy
Non-CME Credit Course
What is the Best Way to Assess Response to Therapy? Is Complete Pathologic Response the Best Surrogate?
Targeted Therapy
Non-CME Credit Course
Existing and Emerging Tests for Cancer Interception: How Low do We have to Go (with the LOD)? Does Methylation Help?
Targeted Therapy
Non-CME Credit Course
Role of SHP2 Inhibitors Alone or in Combination
Targeted Therapy
Non-CME Credit Course
Pan-KRAS Inhibitors: Where are We Going?
Targeted Therapy
Non-CME Credit Course
How to Rescue Patients from Osimertinib Resistance
Targeted Therapy
Non-CME Credit Course
How to Improve Targeted Therapy in NSCLC? Where are the Major Gaps?
Targeted Therapy
Non-CME Credit Course
Mechanisms of Resistance to ALK Inhibitors
Targeted Therapy
Non-CME Credit Course
ALK in Front Line Therapy: Second or Third Generation TKI Inhibitors. What Can Help Us to Choose the Best Therapeutic Agent?
Targeted Therapy
Non-CME Credit Course
Metastatic Targeted Therapy Updates
Targeted Therapy
Non-CME Credit Course
Case Study Molecular Testing
Targeted Therapy
Non-CME Credit Course
Medical Marijuana: Who, When & How?
Targeted Therapy
Non-CME Credit Course
What Have We Learned from the Use Of Medical Marijuana: Myths and Facts
Targeted Therapy
Non-CME Credit Course
Guidelines for Hormone Therapy in Breast Cancer
Targeted Therapy
Non-CME Credit Course
Targeted Therapy in Lung Cancer Updates
Targeted Therapy
Non-CME Credit Course
New Directions in Adjuvant Endocrine Therapy
Targeted Therapy
Non-CME Credit Course
Targeted Therapy for Metastatic HR+/HER2- Breast Cancer: CDK4/6 and PI3K
Targeted Therapy
Non-CME Credit Course
Challenging Cases in Oncology
Targeted Therapy
Non-CME Credit Course
Targeted Therapy
Targeted Therapy
Non-CME Credit Course
Lung Targeted Therapies in NSCLC - BRAF, RET, MET and NTRK
Targeted Therapy
Non-CME Credit Course
What's New in Hematopoietic Stem Cell Transplantation?
Targeted Therapy
Non-CME Credit Course
What Lies Beyond EGFR, ALK And ROS1 Targeted Therapies?
Targeted Therapy
Non-CME Credit Course
Novel Innovations in Proton Therapy
Targeted Therapy
Non-CME Credit Course
Updates in Targeted Therapy and Percision Oncology
Targeted Therapy
Non-CME Credit Course
Targeted Therapy in Sarcomas and Gastrointestinal Stromal Tumors
Targeted Therapy
Non-CME Credit Course
Targeted Therapy & Immunotherapy in HNSCC
Targeted Therapy
Non-CME Credit Course
Indentification and Management of Tyrosine Kinase Inhibitors (TKIs) Toxicities
Targeted Therapy
Non-CME Credit Course
Current Status and Future Potential of Proton Therapy
Targeted Therapy
Non-CME Credit Course
Uncommon Mutations: RET, MET, NTRK, & BRAF
Targeted Therapy
Non-CME Credit Course
Management of Common Toxicities Encountered With Checkpoint Inhibitors
Targeted Therapy
Non-CME Credit Course
Targeted Therapies in Cancer: Is Targeting the Same Mutation Relevant Across Histology and Tumor Type?
Targeted Therapy
Non-CME Credit Course
Managing Toxicities from B-RAF and MEKInhibitors
Targeted Therapy
Non-CME Credit Course
Handling the Most Common Toxicitiesfrom IO - Endocrinopathies,Pneumonitis, Skin Rash Pruritus and Adrenal Insufficiency
Targeted Therapy
Non-CME Credit Course
Oncologic Emergencies The Oncology Nurse Role
Targeted Therapy
Non-CME Credit Course
Modern Antiemetics during Cancer Therapy
Targeted Therapy
Non-CME Credit Course
How to Monitor and Management Complications from Direct Thrombin Inhibitors
Targeted Therapy
Non-CME Credit Course
Precision Medicine in an Era of Value Based Medicine
Targeted Therapy
Non-CME Credit Course
Immune Checkpoint Inhibitors in Cancer Patients with Autoimmune Disease
Targeted Therapy
Non-CME Credit Course
Cancer Treatment Induced Bone Loss (CTIBL)_ RANK Ligand, Bisphosphonate, Anti-angiogenesis, and More
Targeted Therapy
Non-CME Credit Course
Marijuana Use in Cancer: Myths and Reality
Targeted Therapy
Non-CME Credit Course
What Lies Beyond EGFR, ALKAND ROS1 Targeted Therapies
Targeted Therapy
Non-CME Credit Course
Chemoembolization, Radioembolization, and Focal Ablation in Oncology
Targeted Therapy
Non-CME Credit Course
Other Targeted Agents in NSCLC
Targeted Therapy
Non-CME Credit Course
Novel Targets: HER-2, NRG1, TROP2, CEACAM5 & HER-3
Targeted Therapy
Non-CME Credit Course
ALK: Choosing 1L & Mechanism of Resistance
Targeted Therapy
Non-CME Credit Course
Other Targetable Agents (KRASg 12c, BRafv600, RET and NTRK)
Targeted Therapy
Non-CME Credit Course
Identifying and Targeting Mechanisms of Resistance to 3rd Generation EGFR Inhibitors
Targeted Therapy
Non-CME Credit Course
Bispecific Antibodies in Cancer Care: Actual Reality and Future Projections
Targeted Therapy
Non-CME Credit Course
Antibody Drug Conjugates: New Agents and Optimal Sequencing
Targeted Therapy
Non-CME Credit Course
Cannabis and Cancer: Myths and Reality
Targeted Therapy
Non-CME Credit Course
Medical Marijuana in Oncology - Myths and Reality
Targeted Therapy
Non-CME Credit Course
Contact Us
